Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Oncol.

Sec. Head and Neck Cancer

This article is part of the Research TopicFerroptosis: Intersections, Implications, and Innovations in Programmed Cell Death, Volume IIView all 4 articles

The Critical Role of Ferroptosis in Thyroid Cancer Development and Potential Therapeutic Implications

Provisionally accepted
  • 1Shandong University of Traditional Chinese Medicine, Jinan, China
  • 2Nanjing University of Chinese Medicine, Nanjing, China
  • 3Southeast University Zhongda Hospital, Nanjing, China
  • 4First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
  • 5Sichuan University West China Hospital Center of Gerontology and Geriatrics, Chengdu, China
  • 6Nanjing Tongren Hospital, Nanjing, China
  • 7Shandong University of Traditional Chinese Medicine Second Affiliated Hospital, Jinan, China

The final, formatted version of the article will be published soon.

Thyroid cancer is the most common malignant tumour in the endocrine system, and the global diagnosis rate continues to show a steady upward trend. Although significant progress has been made in surgery, radioactive iodine therapy and Thyroid-Stimulating Hormone (TSH) inhibition therapy, patients still often face the dilemma of tumour recurrence or gradual reduction in efficacy, which makes long-term disease management still challenging. Ferroptosis, as an iron-dependent method of programmed death of cells, has become the core focus of current research. This distinct lethal mechanism is driven by iron-dependent lipid peroxidation. In thyroid cancer research, ferroptosis shows important research value and potential therapeutic significance. This article sorts out the role of ferroptosis in the development and immune regulation of thyroid cancer, explores the mutual influence between it and the environment around the tumour, and focusses on analysing its possible application value in disease diagnosis, prognosis and new treatment development. In general, ferroptosis provides a new research direction for understanding thyroid cancer, and may also open up a new path for clinical treatment. However, at present, most of the relevant evidence comes from basic experiments and animal models. It is still necessary to further study its specific mechanism of action in human body and verify the possibility of its clinical application.

Keywords: ferroptosis, Immune Regulation, therapeutic strategies, thyroid cancer, TME

Received: 14 Dec 2025; Accepted: 09 Feb 2026.

Copyright: © 2026 Yinghao, Qian, Han, Wang, Zhang, Huang, Gu, Zhang, Lin, Wang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Jianhua Wang
Shouqiang Chen

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.